Increasing complexity of farnesyltransferase inhibitors activity: Role in chromosome instability

Carla Falugi, Sonya Trombino, Pierluigi Granone, Stefano Margaritora, Patrizia Russo

Research output: Contribution to journalArticle

Abstract

Oncogenic Ras proteins have been seen as an important target for novel anticancer drugs. Due to the functional role of Ras farnesylation, fanesyltransferase (FTase) inhibition was thought to be a strategy for interfering with Ras-dependent transformation. When farnesylation is blocked, the function of Ras protein is severely impaired because of the inability of the nonfarnesylated protein to anchor to the membrane. Although it has been clearly demonstrated that FTase inhibitors (FTIs) inhibit Ras farnesylation, it is uncertain whether the antiproliferative effects of these compounds result exclusively from the effects on Ras. Moreover, no consensus has been reached as to the relevant targets(s) of FTIs that can explain their mosaic pharmacology. In searching for downstream targets for FTIs effects, CENP-E and CENP-F/mitosin were identified. Different studies showed that the inhibition of farnesylation interferes with CENP-E-microtubule association. In the presence of FTIs, chromosome alignment to the metaphase plate is delayed, suggesting that farnesylated proteins are involved in a step critical to bipolar spindle formation and chromosome alignment. An important question is whether these biological effects might contribute to the chemotherapeutic effects of the FTIs. However, FTIs, triggering the spindle checkpoint, might elevate the rate of cellular missegregation to levels that are incompatible with cell viability, as well as have a reduced (but still significant?) effect on checkpointproficient normal cells. As an example, RPR-115135 induced micronuclei (MN) increase in cancer cells displaying high chromosome instability (CIN) levels, whereas in normal cells it is devoid of activity. Cancer cells showing high CIN level might represent an ideal target for the activity of some FTIs.

Original languageEnglish
Pages (from-to)109-118
Number of pages10
JournalCurrent Cancer Drug Targets
Volume3
Issue number2
DOIs
Publication statusPublished - Apr 2003

Fingerprint

Farnesyltranstransferase
Prenylation
Chromosomal Instability
ras Proteins
Chromosomes
Metaphase
Microtubules
Neoplasms
Cell Survival
Proteins
Pharmacology
Membranes
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Cancer Research

Cite this

Increasing complexity of farnesyltransferase inhibitors activity : Role in chromosome instability. / Falugi, Carla; Trombino, Sonya; Granone, Pierluigi; Margaritora, Stefano; Russo, Patrizia.

In: Current Cancer Drug Targets, Vol. 3, No. 2, 04.2003, p. 109-118.

Research output: Contribution to journalArticle

Falugi, Carla ; Trombino, Sonya ; Granone, Pierluigi ; Margaritora, Stefano ; Russo, Patrizia. / Increasing complexity of farnesyltransferase inhibitors activity : Role in chromosome instability. In: Current Cancer Drug Targets. 2003 ; Vol. 3, No. 2. pp. 109-118.
@article{3b8392a518464cf182f71834bd844249,
title = "Increasing complexity of farnesyltransferase inhibitors activity: Role in chromosome instability",
abstract = "Oncogenic Ras proteins have been seen as an important target for novel anticancer drugs. Due to the functional role of Ras farnesylation, fanesyltransferase (FTase) inhibition was thought to be a strategy for interfering with Ras-dependent transformation. When farnesylation is blocked, the function of Ras protein is severely impaired because of the inability of the nonfarnesylated protein to anchor to the membrane. Although it has been clearly demonstrated that FTase inhibitors (FTIs) inhibit Ras farnesylation, it is uncertain whether the antiproliferative effects of these compounds result exclusively from the effects on Ras. Moreover, no consensus has been reached as to the relevant targets(s) of FTIs that can explain their mosaic pharmacology. In searching for downstream targets for FTIs effects, CENP-E and CENP-F/mitosin were identified. Different studies showed that the inhibition of farnesylation interferes with CENP-E-microtubule association. In the presence of FTIs, chromosome alignment to the metaphase plate is delayed, suggesting that farnesylated proteins are involved in a step critical to bipolar spindle formation and chromosome alignment. An important question is whether these biological effects might contribute to the chemotherapeutic effects of the FTIs. However, FTIs, triggering the spindle checkpoint, might elevate the rate of cellular missegregation to levels that are incompatible with cell viability, as well as have a reduced (but still significant?) effect on checkpointproficient normal cells. As an example, RPR-115135 induced micronuclei (MN) increase in cancer cells displaying high chromosome instability (CIN) levels, whereas in normal cells it is devoid of activity. Cancer cells showing high CIN level might represent an ideal target for the activity of some FTIs.",
author = "Carla Falugi and Sonya Trombino and Pierluigi Granone and Stefano Margaritora and Patrizia Russo",
year = "2003",
month = "4",
doi = "10.2174/1568009033482056",
language = "English",
volume = "3",
pages = "109--118",
journal = "Current Cancer Drug Targets",
issn = "1568-0096",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Increasing complexity of farnesyltransferase inhibitors activity

T2 - Role in chromosome instability

AU - Falugi, Carla

AU - Trombino, Sonya

AU - Granone, Pierluigi

AU - Margaritora, Stefano

AU - Russo, Patrizia

PY - 2003/4

Y1 - 2003/4

N2 - Oncogenic Ras proteins have been seen as an important target for novel anticancer drugs. Due to the functional role of Ras farnesylation, fanesyltransferase (FTase) inhibition was thought to be a strategy for interfering with Ras-dependent transformation. When farnesylation is blocked, the function of Ras protein is severely impaired because of the inability of the nonfarnesylated protein to anchor to the membrane. Although it has been clearly demonstrated that FTase inhibitors (FTIs) inhibit Ras farnesylation, it is uncertain whether the antiproliferative effects of these compounds result exclusively from the effects on Ras. Moreover, no consensus has been reached as to the relevant targets(s) of FTIs that can explain their mosaic pharmacology. In searching for downstream targets for FTIs effects, CENP-E and CENP-F/mitosin were identified. Different studies showed that the inhibition of farnesylation interferes with CENP-E-microtubule association. In the presence of FTIs, chromosome alignment to the metaphase plate is delayed, suggesting that farnesylated proteins are involved in a step critical to bipolar spindle formation and chromosome alignment. An important question is whether these biological effects might contribute to the chemotherapeutic effects of the FTIs. However, FTIs, triggering the spindle checkpoint, might elevate the rate of cellular missegregation to levels that are incompatible with cell viability, as well as have a reduced (but still significant?) effect on checkpointproficient normal cells. As an example, RPR-115135 induced micronuclei (MN) increase in cancer cells displaying high chromosome instability (CIN) levels, whereas in normal cells it is devoid of activity. Cancer cells showing high CIN level might represent an ideal target for the activity of some FTIs.

AB - Oncogenic Ras proteins have been seen as an important target for novel anticancer drugs. Due to the functional role of Ras farnesylation, fanesyltransferase (FTase) inhibition was thought to be a strategy for interfering with Ras-dependent transformation. When farnesylation is blocked, the function of Ras protein is severely impaired because of the inability of the nonfarnesylated protein to anchor to the membrane. Although it has been clearly demonstrated that FTase inhibitors (FTIs) inhibit Ras farnesylation, it is uncertain whether the antiproliferative effects of these compounds result exclusively from the effects on Ras. Moreover, no consensus has been reached as to the relevant targets(s) of FTIs that can explain their mosaic pharmacology. In searching for downstream targets for FTIs effects, CENP-E and CENP-F/mitosin were identified. Different studies showed that the inhibition of farnesylation interferes with CENP-E-microtubule association. In the presence of FTIs, chromosome alignment to the metaphase plate is delayed, suggesting that farnesylated proteins are involved in a step critical to bipolar spindle formation and chromosome alignment. An important question is whether these biological effects might contribute to the chemotherapeutic effects of the FTIs. However, FTIs, triggering the spindle checkpoint, might elevate the rate of cellular missegregation to levels that are incompatible with cell viability, as well as have a reduced (but still significant?) effect on checkpointproficient normal cells. As an example, RPR-115135 induced micronuclei (MN) increase in cancer cells displaying high chromosome instability (CIN) levels, whereas in normal cells it is devoid of activity. Cancer cells showing high CIN level might represent an ideal target for the activity of some FTIs.

UR - http://www.scopus.com/inward/record.url?scp=0037379694&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037379694&partnerID=8YFLogxK

U2 - 10.2174/1568009033482056

DO - 10.2174/1568009033482056

M3 - Article

C2 - 12678714

AN - SCOPUS:0037379694

VL - 3

SP - 109

EP - 118

JO - Current Cancer Drug Targets

JF - Current Cancer Drug Targets

SN - 1568-0096

IS - 2

ER -